Page 71 - Petelin, Ana, Nejc Šarabon, Boštjan Žvanut, eds. 2017. Zdravje delovno aktivne populacije ▪︎ Health of the Working-Age Population. Proceedings. Koper: Založba Univerze na Primorskem/University of Primorska Press
P. 71
ta-amyloid toxicity, and astrocyte function. Journal of Neurochemistry, ketogenic diet and its impact on mental processes of working population 69
vol. 134, no. 1, pp. 7-20.
KRIKORIAN, R. et al. 2012. Dietary ketosis enhances memory in mild cogni-
tive impairment. Neurobiol Aging, vol. 33, no. 2, pp. 425 e419-427.
LIŚKIEWICZ, A., JĘDRZEJOWSKA-SZYPUŁKA, H. and LEWIN-KOWA-
LIK, J. 2012. Characteristics of ketogenic diet and its therapeutic prop-
erties in central nervous system disorders. Annales Academiae Medicae
Silesiensis.
MAALOUF, M., RHO, J.M. and MATTSON, M.P. 2009. The neuroprotective
properties of calorie restriction, the ketogenic diet, and ketone bodies.
Brain Research Reviews, vol. 59, no. 2, pp. 293-315.
MANDLA, U., SHARMA, P. and SHARMA, V. 2013. Dietary Factors in
Alzheimer‘s Disease: A Compilation of Helping Evidences. Internation-
al Journal of Research and Development in Pharmacy and Life Sciences, vol.
2, no. 5, pp. 545-552.
MASINO, S.A. and GEIGER, J.D. 2008. Are purines mediators of the anticon-
vulsant/neuroprotective effects of ketogenic diets? Trends in Neuroscienc-
es, vol. 31, no. 6, pp. 273-278.
MCCARTY, M.F., DINICOLANTONIO, J.J. and O‘KEEFE, J.H. 2015. Ketosis
may promote brain macroautophagy by activating Sirt1 and hypoxia-in-
ducible factor-1. Medical Hypotheses, vol. 85, no. 5, pp. 631-639.
MILDER, J. and PATEL, M. 2012. Modulation of oxidative stress and mito-
chondrial function by the ketogenic diet. Epilepsy Research, vol. 100, no.
3, pp. 295-303.
NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE. 2017. Bolezni [online]: Na-
cionalni inštitut za javno zdravje. Available at: http://www.nijz.si/sl/po-
drocja-dela/nenalezljive-bolezni-in-stanja/bolezni [Accessed 17.6. 2017].
NEWMAN, J.C. and VERDIN, E. 2014. Ketone bodies as signaling metabo-
lites. Trends in Endocrinology and Metabolism, vol. 25, no. 1, pp. 42-52.
NOAKES, T.D. and WINDT, J. 2017. Evidence that supports the prescription
of low-carbohydrate high-fat diets: a narrative review. British Journal of
Sports Medicine, vol. 51, no. 2, pp. 133-139.
OHNUMA, T. et al. 2016. Benefits of use, and tolerance of, medium-chain
triglyceride medical food in the management of Japanese patients with
Alzheimer‘s disease: a prospective, open-label pilot study. Clinical Inter-
ventions in Aging, vol. 11, pp. 29-36.
OLIVEIRA, C.L. et al. 2017. A Nutritional Perspective of Ketogenic Diet in Can-
cer: A Narrative Review. Journal of the Academy of Nutrition and Dietetics.
PAGE, K.A. et al. 2009. Medium-chain fatty acids improve cognitive function
in intensively treated type 1 diabetic patients and support in vitro synap-
tic transmission during acute hypoglycemia. Diabetes, vol. 58, no. 5, pp.
1237-1244.
vol. 134, no. 1, pp. 7-20.
KRIKORIAN, R. et al. 2012. Dietary ketosis enhances memory in mild cogni-
tive impairment. Neurobiol Aging, vol. 33, no. 2, pp. 425 e419-427.
LIŚKIEWICZ, A., JĘDRZEJOWSKA-SZYPUŁKA, H. and LEWIN-KOWA-
LIK, J. 2012. Characteristics of ketogenic diet and its therapeutic prop-
erties in central nervous system disorders. Annales Academiae Medicae
Silesiensis.
MAALOUF, M., RHO, J.M. and MATTSON, M.P. 2009. The neuroprotective
properties of calorie restriction, the ketogenic diet, and ketone bodies.
Brain Research Reviews, vol. 59, no. 2, pp. 293-315.
MANDLA, U., SHARMA, P. and SHARMA, V. 2013. Dietary Factors in
Alzheimer‘s Disease: A Compilation of Helping Evidences. Internation-
al Journal of Research and Development in Pharmacy and Life Sciences, vol.
2, no. 5, pp. 545-552.
MASINO, S.A. and GEIGER, J.D. 2008. Are purines mediators of the anticon-
vulsant/neuroprotective effects of ketogenic diets? Trends in Neuroscienc-
es, vol. 31, no. 6, pp. 273-278.
MCCARTY, M.F., DINICOLANTONIO, J.J. and O‘KEEFE, J.H. 2015. Ketosis
may promote brain macroautophagy by activating Sirt1 and hypoxia-in-
ducible factor-1. Medical Hypotheses, vol. 85, no. 5, pp. 631-639.
MILDER, J. and PATEL, M. 2012. Modulation of oxidative stress and mito-
chondrial function by the ketogenic diet. Epilepsy Research, vol. 100, no.
3, pp. 295-303.
NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE. 2017. Bolezni [online]: Na-
cionalni inštitut za javno zdravje. Available at: http://www.nijz.si/sl/po-
drocja-dela/nenalezljive-bolezni-in-stanja/bolezni [Accessed 17.6. 2017].
NEWMAN, J.C. and VERDIN, E. 2014. Ketone bodies as signaling metabo-
lites. Trends in Endocrinology and Metabolism, vol. 25, no. 1, pp. 42-52.
NOAKES, T.D. and WINDT, J. 2017. Evidence that supports the prescription
of low-carbohydrate high-fat diets: a narrative review. British Journal of
Sports Medicine, vol. 51, no. 2, pp. 133-139.
OHNUMA, T. et al. 2016. Benefits of use, and tolerance of, medium-chain
triglyceride medical food in the management of Japanese patients with
Alzheimer‘s disease: a prospective, open-label pilot study. Clinical Inter-
ventions in Aging, vol. 11, pp. 29-36.
OLIVEIRA, C.L. et al. 2017. A Nutritional Perspective of Ketogenic Diet in Can-
cer: A Narrative Review. Journal of the Academy of Nutrition and Dietetics.
PAGE, K.A. et al. 2009. Medium-chain fatty acids improve cognitive function
in intensively treated type 1 diabetic patients and support in vitro synap-
tic transmission during acute hypoglycemia. Diabetes, vol. 58, no. 5, pp.
1237-1244.
